Human Cannabinoid Pharmacokinetics

Cited by (1,000)

Items 301–400 of 1,000

1. Therapeutic potential of cannabinoids in combination cancer therapy
   Pratibha Malhotra, Ilaria Casari, Marco Falasca · 2021 · Advances in Biological Regulation
2. Identification of human hexahydrocannabinol metabolites in urine
   Willi Schirmer, Volker Auwärter, Julia Kaudewitz, Stefan Schürch, Wolfgang Weinmann · 2023 · European Journal of Mass Spectrometry
3. Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
   Prakash Nidadavolu, András Bilkei‐Gorzó, Michael Krämer, Britta Schürmann, Michela Palmisano, Eva Carolina Beins, B Madea, Andreas Zimmer · 2021 · Frontiers in Aging Neuroscience
4. Paper-based electrochemical sensor for simultaneous detection of salivary Δ⁹-tetrahydrocannabinol and thiocyanate to differentiate illegal cannabis smokers
   Tavechai Pholsiri, Wisarut Khamcharoen, Sornkanok Vimolmangkang, Weena Siangproh, Orawon Chailapakul · 2023 · Sensors and Actuators B Chemical
5. A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?
   Ilona Shishko, Rosana Oliveira, Troy A. Moore, Kenneth Almeida · 2018 · Mental Health Clinician
6. Cannabis Use in Older Adults: A Perspective
   Haley V. Solomon, Aaron P. Greenstein, Lynn E. DeLisi · 2021 · Harvard Review of Psychiatry
7. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment
   L. Cinnamon Bidwell, Hollis C. Karoly, Marco Ortiz Torres, Ashley Master, Angela D. Bryan, Kent E. Hutchison · 2021 · Psychopharmacology
8. In vitro effects of cannabidiol and its main metabolites in mouse and human Sertoli cells
   Yuxi Li, Qiangen Wu, Xilin Li, Linda S. Von Tungeln, Frederick A. Beland, Dayton M. Petibone, Lei Guo, Patrick Cournoyer, Supratim Choudhuri, Si Chen · 2021 · Food and Chemical Toxicology
9. An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications
   Elisa Regina Lazzarotto Rebelatto, Gabriela Schneider Rauber, Thiago Caon · 2023 · International Journal of Pharmaceutics
10. Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
    Matthew Preteroti, Emily T. Wilson, David H. Eidelman, Carolyn J. Baglole · 2023 · Respiratory Research
11. Cannabis vaporisation: Understanding products, devices and risks
    Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April L. Christiansen, Michael R. Boivin · 2023 · Drug and Alcohol Review
12. Priority Considerations for Medicinal Cannabis-Related Research
    Marcel O. Bonn‐Miller, Charles V. Pollack, David Casarett, Richard C. Dart, Mahmoud A. ElSohly, Larry I. Good, Manuel Guzmán, Lumír Hanuš, Kevin P. Hill, Marilyn A. Huestis et al. · 2019 · Cannabis and Cannabinoid Research
13. Insights into the role of cannabis in the management of inflammatory bowel disease
    Sherman Picardo, Gilaad G. Kaplan, Keith A. Sharkey, Cynthia H. Seow · 2019 · Therapeutic Advances in Gastroenterology
14. A validated method for the simultaneous quantification of cannabidiol, Δ9‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial
    Richard C. Kevin, Rebecca Vogel, Peter Thomas Doohan, Maximus Berger, G. Paul Amminger, Iain S. McGregor · 2020 · Drug Testing and Analysis
15. Translational models of cannabinoid vapor exposure in laboratory animals
    Catherine F. Moore, Jeffrey W. Stiltner, Catherine M. Davis, Elise M. Weerts · 2020 · Behavioural Pharmacology
16. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
    Newman Osafo, Kofi Oduro Yeboah, Aaron Opoku Antwi · 2021 · Molecular Biology Reports
17. Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?
    Luke John Ney, Kevin M. Crombie, Leah M. Mayo, Kim Louise Felmingham, Tim A. Bowser, Allison Jane Matthews · 2021 · Neuroscience & Biobehavioral Reviews
18. Risk for involvement in road traffic crash during acute cannabis intoxication
    Hallvard Gjerde, Jørg Gustav Mørland · 2016 · Addiction
19. Physiologically based pharmacokinetic modeling and simulation of cannabinoids in human plasma and tissues
    Yitong Liu, Robert L. Sprando · 2022 · Journal of Applied Toxicology
20. Metabolic, toxicological, chemical, and commercial perspectives on esterification of dietary polyphenols: a review
    Han Peng, Fereidoon Shahidi · 2023 · Critical Reviews in Food Science and Nutrition
21. Adverse Impact of Cannabis on Human Health
    Mark Chandy, Masataka Nishiga, Tzu-Tang Wei, Naomi M. Hamburg, Kari Christine Nadeau, Joseph C. Wu · 2023 · Annual Review of Medicine
22. Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis
    Ehsan Moazen Zadeh, Alexandra Chisholm, Keren Bachi, Yasmin L. Hurd · 2023 · Cannabis and Cannabinoid Research
23. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol
    Maged Saad Abdel-Kader, Mohamed M. Radwan, Ahmed M. Metwaly, Ibrahim H. Eissa, Arno Hazekamp, Mahmoud A. ElSohly · 2024 · Molecules
24. FABP ‐1 gene ablation impacts brain endocannabinoid system in male mice
    Gregory G. Martin, Sarah Chung, Danilo Landrock, Kerstin K. Landrock, Huan Huang, Lawrence J. Dangott, Xiaoxue Peng, Martin Kaczocha, Drew R. Seeger, Eric J. Murphy et al. · 2016 · Journal of Neurochemistry
25. Medical marijuana in pediatric oncology: A review of the evidence and implications for practice
    Prasanna Janaki Ananth, Anne E. Reed-Weston, Joanne Wolfe · 2017 · Pediatric Blood & Cancer
26. Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids
    Michael Moir, Samuel D. Lane, Felcia Lai, Mark A. Connor, David E. Hibbs, Michael Kassiou · 2019 · European Journal of Medicinal Chemistry
27. “Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review.”
    Yuan Wei Peng, Ediriweera Desapriya, Herbert Chan, Jeffrey Reynold Brubacher · 2020 · Drug and Alcohol Dependence
28. Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy
    Terence John O'Brien, Samuel Frank Berkovic, Jacqueline A. French, John A. Messenheimer, Terri B. Sebree, Marcel O. Bonn‐Miller, Donna L. Gutterman, STAR 1/STAR 2 Study Group, Manori Wijayath, Peter T. Patrikios et al. · 2022 · JAMA Network Open
29. Post‐mortem redistribution of drugs and other factors affecting interpretation: A review
    Olaf H. Drummer, Dimitri Gerostamoulos · 2023 · Wiley Interdisciplinary Reviews Forensic Science
30. CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
    Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, Zhu Zhou · 2024 · Pharmaceutics
31. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Dayong Lee, Erin L Karschner, Garry Milman, Allan J. Barnes, Robert S. Goodwin, Marilyn Ann Huestis · 2012 · Drug and Alcohol Dependence
32. Tackling the Problem of Sensing Commonly Abused Drugs Through Nanomaterials and (Bio)Recognition Approaches
    Florina Maria Truta, Anca Florea, Andreea Cernat, Mihaela Tertiş, Oana Hosu, Karolien De Wael, Cécilia Cristea · 2020 · Frontiers in Chemistry
33. ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology
    Kenzi Riboulet-Zemouli · 2020 · Drug Science Policy and Law
34. Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study
    Ran Abuhasira, Yosef Shmuel Haviv, Merav Leiba, Adi Leiba, Larisa Ryvo, Victor Novack · 2021 · European Journal of Internal Medicine
35. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market
    Andrew M. Brandon, Lysbeth H. Antonides, Jennifer Riley, Ola Epemolu, Denise A. McKeown, Kevin D. Read, Craig McKenzie · 2021 · Molecules
36. Investigating the “two-hit hypothesis”: Effects of prenatal maternal immune activation and adolescent cannabis use on neurodevelopment in mice
    Elisa Guma, Lani Cupo, Weiya Ma, Daniel Gallino, Luc Moquin, Alain P. Gratton, Gabriel A. Devenyi, M. Mallar Chakravarty · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
37. The antinociceptive activity and mechanism of action of cannabigerol
    Yuting Wen, Zefeng Wang, Rui Zhang, Yuying Zhu, Guo‐Qiang Lin, Ruixiang Li, Jiange Zhang · 2023 · Biomedicine & Pharmacotherapy
38. Cannabis and Pregnancy: A Review
    Sarena Hayer, Ava D. Mandelbaum, Lester Watch, Kimberly S. Ryan, Madeline A. Hedges, Jennifer A. Manuzak, Charles A. Easley, Danny Joseph Schust, Jamie Oi-Ting Lo · 2023 · Obstetrical & Gynecological Survey
39. Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders
    Christopher Noel · 2017 · Mental Health Clinician
40. Contemporary Routes of Cannabis Consumption: A Primer for Clinicians
    Jeramy Peters, Joseph Chien · 2018 · Journal of Osteopathic Medicine
41. A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors
    Yang Miao, Fei Zhao, Wei Guan · 2024 · The International Journal of Neuropsychopharmacology
42. Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
    Brooks W. Johnson, Natalie H. Strand, John Raynak, Christian Jara, Kisanet Habtegiorgis, Brennan A. Hand, Sang Hong, Jillian A. Maloney · 2025 · Biomedicines
43. Cannabis use: a perspective in relation to the proposed UK drug‐driving legislation
    Kim Wolff, A. E. Johnston · 2013 · Drug Testing and Analysis
44. Medicinal Cannabis in Orthopaedic Practice
    Lindsay T. Kleeman-Forsthuber, Douglas A. Dennis, Jason M. Jennings · 2019 · Journal of the American Academy of Orthopaedic Surgeons
45. The effects of delta-9-tetrahydrocannabinol (THC) on inflammation: A review
    Henry P. Miller, Steven C. Bonawitz, Olga Ostrovsky · 2020 · Cellular Immunology
46. Phytocannabinoid drug-drug interactions and their clinical implications
    Daniela Amaral Silva, David W. Pate, Robert D. Clark, Neal M. Davies, Ayman O.S. El‐Kadi, Raimar Löbenberg · 2020 · Pharmacology & Therapeutics
47. Use of Cannabis and Cannabinoids in Patients With Cancer
    Lindsey Sawtelle, Lisa M. Holle · 2020 · Annals of Pharmacotherapy
48. Analysis of 39 drugs and metabolites, including 8 glucuronide conjugates, in an upstream wastewater network via HPLC-MS/MS
    Katelyn S. Foppe, Elizabeth B. Kujawinski, Claire Duvallet, Noriko Endo, Timothy B. Erickson, Peter Ray Chai, Mariana G. Matus · 2021 · Journal of Chromatography B
49. Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells
    Yuxi Li, Xilin Li, Patrick Cournoyer, Supratim Choudhuri, Xiaozhong Yu, Lei Guo, Si Chen · 2022 · Toxicological Sciences
50. Sensitive Quantification of Cannabinoids in Milk by Alkaline Saponification–Solid Phase Extraction Combined with Isotope Dilution UPLC–MS/MS
    Binnian Wei, James E. McGuffey, Benjamin C. Blount, Lanqing Wang · 2016 · ACS Omega
51. Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
    Caitlin R. M. Oyagawa, Sara M. de la Harpe, Yurii Saroz, Michelle Glass, Andrea J. Vernall, Natasha Lillia Grimsey · 2018 · Frontiers in Pharmacology
52. Effectiveness of Cannabidiol to Manage Chronic Pain: A Systematic Review
    Sherin Yasser Mostafa Mohammed, Kaizielyn Leis, Ria Eunice Mercado, Ma. Monica Sheiane Castillo, Kevin Jace Miranda, Rogie Royce Carandang · 2023 · Pain Management Nursing
53. Human metabolism of the semi‐synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples
    Karin Lindbom, Caitlyn Norman, Steven R. Baginski, Lucas Krebs, Dārta Štālberga, Tobias Rautio, Xiongyu Wu, Robert Kronstrand, Henrik Gréen · 2024 · Drug Testing and Analysis
54. The Dilemma of Medical Marijuana Use by Rheumatology Patients
    Mary‐Ann Fitzcharles, Daniel Joseph Clauw, Peter A. Ste‐Marie, Yoram Shir · 2014 · Arthritis Care & Research
55. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability
    Dvora Izgelov, Irina Cherniakov, Gefen Aldouby-Bier, Abraham Jacob Domb, Amnon Hoffman · 2018 · Molecular Pharmaceutics
56. Marijuana: the effects on pregnancy, the fetus, and the newborn
    Gilbert I. Martin · 2020 · Journal of Perinatology
57. Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice
    Marta Kruk-Słomka, Grażyna Biała · 2021 · Molecules
58. Cannabis edibles packaging: Communicative objects in a growing market
    Matt Ventresca, Charlene D Elliott · 2022 · International Journal of Drug Policy
59. Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding
    Anaëlle Monfort, Ema Ferreira, Grégoire Leclair, Gregory Anton Lodygensky · 2022 · Frontiers in Pharmacology
60. Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults
    Laura MacNair, Justyna Kulpa, Melanie L. Hill, Graham M.L. Eglit, Irina Mosesova, Marcel O. Bonn‐Miller, Erica N. Peters · 2023 · Cannabis and Cannabinoid Research
61. Association Between Use of Cannabis in Adolescence and Weight Change into Midlife
    Lexie Zhiyan Jin, Anna Rangan, Jesper Mehlsen, Lars Bo Andersen, Sofus Christian Larsen, Berit L. Heitmann · 2017 · PLoS ONE
62. Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
    Natalie Ertl, Tom P. Freeman, Claire Mokrysz, Shelan Ofori, Anna Borissova, Kat Petrilli, H. Valerie Curran, Will Lawn, Matthew B. Wall · 2024 · Neuropsychopharmacology
63. hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation
    Cláudia C. Miranda, Tiago Barata, Sandra Henriques Vaz, Carla Ferreira, Alexandre Quintas, Evguenia Bekman · 2020 · Frontiers in Molecular Neuroscience
64. Cannabinoid Receptor Type 2 Ligands: An Analysis of Granted Patents Since 2010
    Benjamin Brennecke, Thais Gazzi, Kenneth Atz, Jürgen Fingerle, Pascal Kuner, Torsten Schindler, G. DE WECK, Marc Nazaré, Uwe Grether · 2021 · Pharmaceutical Patent Analyst
65. A review of the effects of acute and chronic cannabinoid exposure on the stress response
    Nicholas C. Glodosky, Carrie Cuttler, Ryan J. McLaughlin · 2021 · Frontiers in Neuroendocrinology
66. SPME as a green sample-preparation technique for the monitoring of phytocannabinoids and endocannabinoids in complex matrices
    Katarzyna Woźniczka, Paweł Konieczyński, Alina Plenis, Tomasz Bączek, Anna Roszkowska · 2023 · Journal of Pharmaceutical Analysis
67. Analysis of Δ9-tetrahydrocannabinol Driving Under the Influence of Drugs Cases in Colorado from January 2011 to February 2014
    Sarah Urfer, Jaime Morton, Vanessa Beall, Jeanna Feldmann, Justin T. Gunesch · 2014 · Journal of Analytical Toxicology
68. Cannabis and crash responsibility while driving below the alcohol per se legal limit
    Eduardo O. Romano, Robert B. Voas, Bayliss J. Camp · 2017 · Accident Analysis & Prevention
69. Determination of Cannabinoids in Breast Milk Using QuEChERS and Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry
    Rhea S Ramnarine, Justin L. Poklis, Carl E. Wolf · 2019 · Journal of Analytical Toxicology
70. Method for Postmortem Quantification of Δ9-Tetrahydrocannabinol and Metabolites Using LC–MS–MS
    Ahmed Ibrahim Al-Asmari · 2019 · Journal of Analytical Toxicology
71. Pharmacological evidence of medicinal cannabis in oncology: a systematic review
    Danielle Brown, Michael Watson, Janet Margaret Schloss · 2019 · Supportive Care in Cancer
72. Medical marijuana use for pediatric oncology patients: single institution experience
    Ruth Ofir, Gil Bar‐Sela, Myriam Weyl Ben‐Arush, Sergey Postovsky · 2019 · Pediatric Hematology and Oncology
73. Marijuana Use and Potential Implications of Marijuana Legalization
    Tamara M. Grigsby, Laurel Murphy Hoffmann, Michael J. Moss · 2020 · Pediatrics in Review
74. Optimization of supercritical carbon dioxide fluid extraction of seized cannabis and self-emulsifying drug delivery system for enhancing the dissolution of cannabis extract
    Monton, Chaowalit, Chankana, Natawat, Leelawat, Surang, Suksaeree, Jirapornchai, Songsak, Thanapat · 2022 · The Journal of Supercritical Fluids
75. Comparative Pharmacokinetics of Δ 9 -Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats
    Alexa Torrens, Pritam Roy, Lin Lin, Cindy Vu, Dakota Grimes, Victoria C. Inshishian, Johanna S. Montesinos, Faizy Ahmed, Stephen V. Mahler, Marylin A. Huestis et al. · 2022 · Cannabis and Cannabinoid Research
76. Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant
    Abhigyan Ravula, Hardik Chandasana, Barry Setlow, Marcelo Febo, Adriaan W. Bruijnzeel, Hartmut Derendorf · 2018 · Journal of Pharmaceutical and Biomedical Analysis
77. Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis
    Ana Pilar Pérez-Acevedo, Roberta Pacifici, Giulio Mannocchi, Massimo Gottardi, Lourdes Poyatos, Esther Papaseit, Clara Pérez‐Mañá, Soraya Martín, Francesco Paolo Busardò, Simona Pichini et al. · 2020 · Phytotherapy Research
78. Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
    Johannes Beiersdorf, Zsófia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman A. Romanov, Edit Szodorai, Gert Lübec, Sally L. Shirran, Catherine H. Botting, Siegfried F. Kasper et al. · 2020 · JCI Insight
79. A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
    Judith Helen Cross, Hannah R. Cock · 2019 · Neuropharmacology
80. Pharmacists and the future of cannabis medicine
    Natalie S. Schmitz, Lucas Richert · 2019 · Journal of the American Pharmacists Association
81. Acute neuroradiological, behavioral, and physiological effects of nose-only exposure to vaporized cannabis in C57BL/6 mice
    Yasmeen M. Farra, Matthew Eden, James R. Coleman, Praveen P. Kulkarni, Craig F. Ferris, Jessica M. Oakes, Chiara Maria Bellini · 2020 · Inhalation Toxicology
82. Determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 33 compounds from eight different drug classes in whole blood by LC-MS/MS
    Benedicte Jørgenrud, Eline Skadberg, Julio De Carvalho Ponce, Håvard Furuhaugen, Thomas Berg · 2020 · Journal of Pharmacological and Toxicological Methods
83. Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol
    Richard Kanyo, Md Ruhul Amin, Laszlo F. Locskai, Danika D. Bouvier, Alexandria M. Olthuis, W. Ted Allison, Declan W. Ali · 2021 · Scientific Reports
84. Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats
    Jenny L. Wiley, Shanequa I. Taylor, Julie A. Marusich · 2021 · Drug and Alcohol Dependence
85. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
    Nicholas H. B. Schräder, Emily S. Gorell, Roy E. Stewart, José C. Duipmans, Nicole Harris, Victoria Aurora Ferrer Pérez, Jean Yuh Tang, André Paul Wolff, Maria C. Bolling · 2021 · Orphanet Journal of Rare Diseases
86. Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
    Nathan L. Fearby, Samantha L. Penman, Panayotis K. Thanos · 2022 · International Journal of Environmental Research and Public Health
87. Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America
    Richard Quansah Amissah, Nadine A. Vogt, Chuyun Chen, Karolina Urban, Jibran Younis Khokhar · 2022 · PLoS ONE
88. Nutrient digestibility, rumen parameters, and (cannabinoid) residues in sheep fed a pelleted diet containing green hemp (Cannabis sativa L.) biomass
    Sarah A. Stevens, Gaye Louise Krebs, Colin J. Scrivener, Glenys K. Noble, Bronwyn L. Blake, Ken Dods, Christopher D. May, Z X Tai, Edward H. Clayton, Emma E.M. Lynch et al. · 2022 · Translational Animal Science
89. Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
    Matthias Karst, Sonja Wippermann · 2009 · Expert Opinion on Investigational Drugs
90. Influence of alcohol and other substances of abuse at the time of injury among patients in a Norwegian emergency department
    Eirin Bakke, Stig Tore Bogstrand, Per Trygve Normann, Øivind Ekeberg, Liliana C. Bachs · 2016 · BMC Emergency Medicine
91. Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol
    Matthew J. Smith, Eva Alden, Amy A. Herrold, Andrea G. Roberts, Dan Stern, Joseph Jones, Allan J. Barnes, Kailyn P. O’Connor, Marilyn Ann Huestis, Hans C. Breiter · 2018 · Journal of Studies on Alcohol and Drugs
92. Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation
    Arianna Giorgetti, Lukas Mogler, Belal Haschimi, Sebastian Halter, Florian Franz, Folker Westphal, Svenja Fischmann, Jan Riedel, Michael Pütz, Volker Auwärter · 2019 · Drug Testing and Analysis
93. E-cigarette use is prospectively associated with initiation of cannabis among college students
    Albert J. Ksinan, Tory R. Spindle, Nathaniel Thomas, Thomas Eissenberg, Danielle M. Dick · 2020 · Addictive Behaviors
94. Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States
    Megan M. Lim, Mark G. Kirchhof · 2018 · Journal of Cutaneous Medicine and Surgery
95. THC and CBD blood and brain concentrations following daily administration to adolescent primates
    Sarah Louise Withey, Jack Bergman, Marilyn Ann Huestis, Susan R. George, Bertha Kalifon Madras · 2020 · Drug and Alcohol Dependence
96. The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
    Clara Andradas, Alexandra Truong, Jacob Byrne, Raelene Endersby · 2021 · Cancers
97. Chronic exposure to delta-9-tetrahydrocannabinol impacts testicular volume and male reproductive health in rhesus macaques
    Jason C. Hedges, Carol B. Hanna, Jasper C. Bash, Emily R. Boniface, Fernanda C. Burch, Shruthi Mahalingaiah, Victoria H. J. Roberts, Juanito Jose D. Terrobias, Emily Mishler, Jared V. Jensen et al. · 2022 · Fertility and Sterility
98. Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?
    W. Zieglgänsberger, Rudolf Brenneisen, Achim Berthele, Carsten Tobias Wotjak, Borwin Bandelow, Thomas Rudolf Tölle, Beat Lutz · 2022 · Medical Cannabis and Cannabinoids
99. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study
    Gyula Váradi, Zhen Zhu, Henry D. Crowley, Marc Moulin, Rajib Kumar Dey, Erin Diane Lewis, Malkanthi Evans · 2022 · Advances in Therapy
100. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study
     Lucy A. Chester, Amir Englund, Edward Chesney, Dominic Oliver, Jack Wilson, Simina Sovi, Alex M. Dickens, Matej Orešič, Tuomas Linderman, John P. Hodsoll et al. · 2022 · Cannabis and Cannabinoid Research